ORBIMED ADVISORS LLC
Q3 2025 13F Holdings
- Locationnew york, NY
- Num holdings
110
- Value ($000)
$4,255,380
- Date Filed 11/14/2025
- Form type13F-HR
- CIK 0001055951
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
E EDGEWISE THERAPEUTICS INC | COM | 28036F105 | $251.71M | 6 % | 15,518,492 | ||
B BOSTON SCIENTIFIC CORP | COM | 101137107 | $237.17M | 6 % | 2,429,300 | ||
L ELI LILLY & CO | COM | 532457108 | $229.82M | 5 % | 301,200 | ||
SINOVAC BIOTECH LTD | SHS | P8696W104 | $184.47M | 4 % | 2,718,735 | ||
E ENLIVEN THERAPEUTICS INC | COM | 29337E102 | $162.93M | 4 % | 7,959,538 | ||
A ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | $137.53M | 3 % | 301,600 | ||
S STRYKER CORPORATION | COM | 863667101 | $132.79M | 3 % | 359,200 | ||
E EDWARDS LIFESCIENCES CORP | COM | 28176E108 | $130.96M | 3 % | 1,684,000 | ||
I INTUITIVE SURGICAL INC | COM NEW | 46120E602 | $128.44M | 3 % | 287,200 | ||
A ARGENX SE | SPONSORED ADR | 04016X101 | $127.08M | 3 % | 172,300 |
Rows Per Page
10
- 10
- 50
- 100